Study S000843

GLUCOSE-MGH: Genetic Links Understood Through Challenge With Oral Semaglutide Exposure at MGH

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT06003153
Acronym: GLUCOSE-MGH
Study type: INTERVENTIONAL
Phase: PHASE4
Masking: NONE
Status: RECRUITING
Enrollment: 125
Start: 2024-03-12
Primary completion: 2027-05-31
Lead sponsor: Massachusetts General Hospital
Conditions: Genetic Predisposition; Metabolic Diseases; Type 2 Diabetes
Interventions: DRUG:oral semaglutide; OTHER:Mixed Meal Tolerance Test (MMTT)
Results posted: FALSE
Secondary identifiers: NIH:K23DK131345

Registered primary outcomes

Insulin response to oral semaglutide treatment [15 days]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.